a Cancer Research Campaign Laboratories, Paterson Institute for Cancer Research, Manchester (Great Britain), b Merck, Sharp and Dohme Research Laboratories, West Point, PA (U.S.A.), c Hazleton Microtest, York (Great Britain), a National Institute of Hygienic Sciences, Tokyo (Japan), e Hazleton Laboratories America, Kensington, M D (U.S.A.), I Imperial Chemical Industries, Manchester (Great Brit...

OBJECTIVES The increased incidence of multiple myeloma (MM) across China and East Asia stimulated us to examine the current rates in Great Britain, where rates increased dramatically in the second half of the 20th century. However, rates have been stable and high during this period in Malmö, Sweden, where there is a keen interest in MM. We thus assessed recent changes in MM incidence in Great B...

1 Centre for Computational Finance and Economic Agents (CCFEA), University of Essex, Wivenhoe Park, Colchester CO4 3SQ, Great Britain, E-Mail: [email protected] 2 University of Bath, School of Management, Claverton Down, Bath BA2 7AY, Great Britain, E-Mail: [email protected] 3 Department of Computer Science, University of Essex, Wivenhoe Park, Colchester CO4 3SQ, Great Britain, E-Mail: edward@e...

service Email alerting top right corner of the article Receive free email alerts when new articles cite this article-sign up in the box at the Topic collections (2378 articles) Other ophthalmology (35 articles) Flexible and part time training (105 articles) Working in another country Articles on similar topics can be found in the following collections

Dying to know : public release of information about quality of health care. p. cm. " MR-1255-NT. " Includes bibliographical references. ISBN 0-8330-2891-X 1. Medical care—Great Britain—Quality control. 2. Medical care—United States—Quality control. 3. Consumer education—Great Britain. 4. Consumer education—United States. 5. Medical care—Great Britain—Evaluation. 6. Medical care—United States—Ev...